Impact of asparaginase discontinuation on outcome in childhood ALL: A report from the Children’s Oncology Group (COG).
Sumit Gupta(Dayanand Medical College & Hospital), Meenakshi Devidas(National Institutes of Health), Reuven J. Schore(Children's National), Eric Larsen(University of Massachusetts Chan Medical School), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), Naomi Winick(The University of Texas Southwestern Medical Center), Leonard A. Mattano, Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Wanda L. Salzer(Maine Medical Center), Cindy Wang(University of Florida), Mignon L. Loh(Seattle Children's Hospital)
Cited by 5
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k